Skip to main content

Advertisement

SpringerLink
Log in

Sirolimus-eluting stents versus paclitaxel-eluting stents for coronary intervention in patients with renal failure on hemodialysis

  • Original Article
  • Published:
Cardiovascular Intervention and Therapeutics Aims and scope Submit manuscript

Abstract

Patients undergoing chronic hemodialysis (HD) are at high risk of restenosis and cardiac events after percutaneous coronary intervention (PCI). This study compared the clinical efficacy of sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) in patients undergoing HD. Between June 2004 and January 2010, the clinical outcomes of 41 consecutive patients on HD who underwent PCI with SES (62 lesions) were compared with those of 38 consecutive patients on HD who underwent PCI with PES (54 lesions). Patient and lesion characteristics were similar between both groups. The target lesion revascularization (TLR) (SES 36.6 % vs. PES 15.8 %; P = 0.037) was significantly higher with SES (36.6 %) than with PES (15.8 %) (P = 0.037), particularly in the context of severe calcified lesions that required rotational atherectomy (SES 72.7 % vs. PES 16.7 %; P = 0.0067). However, 1 year after PCI, there was no difference between the two groups in all-cause death, myocardial infarction or major adverse cardiac events. Patients undergoing HD are at a high risk of restenosis after PCI, even when using a drug-eluting stent. The TLR was higher with SES than with PES, particularly when used for severe calcified lesions that required rotational atherectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol. 1999;10:1606–15.

    PubMed  CAS  Google Scholar 

  2. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, et al. The hemodialysis (HEMO) study: atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000;58:353–62.

    Article  PubMed  CAS  Google Scholar 

  3. Naidu SS, Selzer F, Jacobs A, Faxon D, Marks DS, Johnston J, et al. Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. Am J Cardiol. 2003;92:1160–4.

    Article  PubMed  Google Scholar 

  4. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, RAVEL Study Group, et al. A randomized comparison of sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–80.

    Article  PubMed  CAS  Google Scholar 

  5. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, SIRIUS Investigators, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–23.

    Article  PubMed  CAS  Google Scholar 

  6. Schofer J, Schluter M, Gershlick AH, Wijns W, Garcia E, Schampaert E, E-SIRIUS Investigators, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet. 2003;362:1093–9.

    Article  PubMed  CAS  Google Scholar 

  7. Das P, Moliterno DJ, Charnigo R, Mukherjee D, Steinhubl SR, Sneed JD, et al. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. J Invasive Cardiol. 2006;18:405–8.

    PubMed  Google Scholar 

  8. Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. J Invasive Cardiol. 2006;18:577–83.

    PubMed  Google Scholar 

  9. Sen Y, Tanabe K, Tanimoto S, Aoki J, Nakazawa G, Yamamoto H, et al. Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients. Am J Kidney Dis. 2009;54:299–306.

    Article  Google Scholar 

  10. Ahmed A-L, Debabrata M, Paymon M, Khaled MZ. Drug-eluting stents in patients with end-stage renal disease: meta-analysis and systematic review of the literature. Catheter Cardiovasc Interv. 2010;76:942–8.

    Article  Google Scholar 

  11. Takeuchi I, Moriguchi M, Imaki R, Fukaya H, Shinagawa H, Shimohama T, et al. Hemodialysis is an independent predictor of coronary in-stent restenosis after paclitaxel eluting stent implantation. Intern Med. 2010;49:2379–84.

    Article  PubMed  Google Scholar 

  12. Nakamura M, Yokoi H, Hamazaki Y, Watarai M, Kijima M, the Cypher J-PMS Investigators. Impact of insulin-treated diabetes and hemodialysis on long-term clinical outcomes following sirolimus-eluting stent deployment—insights from a sub-study of the Cypher stent Japan post-marketing surveillance (Cypher J-PMS) registry. Circ J. 2010;74:2592–7.

    Article  PubMed  Google Scholar 

  13. Yazaki Y, Iijima R, Nakamura M, Sugi K. Relationships between renal function stage and clinical outcomes after paclitaxel-eluting stent implantation. J Cardiol. 2011;57:61–8.

    Article  PubMed  Google Scholar 

  14. Ishio N, Kobayashi Y, Takebayashi H, Iijima Y, Kanda J, Nakayama T, et al. Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. Circ J. 2007;71:1525–9.

    Article  PubMed  Google Scholar 

  15. Aoyama T, Ishii H, Toriyama T, Takahashi H, Kasuga H, Murakami R, et al. Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J. 2008;72:56–60.

    Article  PubMed  Google Scholar 

  16. Okada T, Hayashi Y, Toyofuku M, Imazu M, Otsuka M, Sakuma T, et al. One-year clinical outcomes of dialysis patients after implantation with sirolimus-eluting coronary stents. Circ J. 2008;72:1430–5.

    Article  PubMed  Google Scholar 

  17. Patterson C, Mapera S, Li HH, Madamanchi N, Hilliard E, Lineberger R, et al. Comparative effects of paclitaxel and rapamycin on smooth muscle migration and survival: role of AKT-dependent signaling. Arterioscler Thromb Vasc Biol. 2006;26:1473–80.

    Article  PubMed  CAS  Google Scholar 

  18. Stettler C, Allemann S, Egger M, Windecker S, Meier B, Diem P. Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials. Heart. 2006;92:650–7.

    Article  PubMed  CAS  Google Scholar 

  19. Mahmud E, Bromberg-Marin G, Palakodeti V, Ang L, Creanga D, Demaria AN. Clinical efficacy of drug-eluting stents in diabetic patients: meta-analysis. J Am Coll Cardiol. 2008;51:2385–95.

    Article  PubMed  CAS  Google Scholar 

  20. Mahmud E, Ormiston JA, Turco MA, Popma JJ, Weissman NJ, O’Shanughnessy CD, et al. TAXUS Libert’e attenuates the risk of restenosis in patients with medically treated diabetes mellitus: results from the TAXUS ATLAS program. JACC Cardiovasc Interv. 2009;2:240–52.

    Article  PubMed  Google Scholar 

  21. Menown I, Noad R, Garcia EJ, Meredith I. The platinum chromium element stent platform: from alloy, to design, to clinical practice. Adv Ther. 2010;27:129–41.

    Article  PubMed  CAS  Google Scholar 

  22. Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant. 2000;15:218–23.

    Article  PubMed  CAS  Google Scholar 

  23. Tanigawa J, Barlis P, Di Mario C. Heavily calcified coronary lesions preclude strut apposition despite high pressure balloon dilatation and rotational atherectomy: in vivo demonstration with optical coherence tomography. Circ J. 2008;72:157–60.

    Article  PubMed  Google Scholar 

  24. Kuriyama N, Kobayashi Y, Nakayama T, Kuroda N, Komuro I. Images in cardiovascular medicine: damage to polymer of sirolimus-eluting stent. Circulation. 2006;114:e586–7.

    Article  PubMed  Google Scholar 

  25. Kawaguchi R, Tsurugaya H, Hoshizaki H, Toyama T, Oshima S, Taniguchi K. Impact of lesion calcification on clinical and angiographic outcome after sirolimus-eluting stent implantation in real-world patients. Cardiovasc Revasc Med. 2008;9:2–8.

    Article  PubMed  Google Scholar 

  26. Fujimoto H, Ishiwata S, Yamaguchi T, Ohno M. Usefulness of rotational atherectomy for the implantation of drug-eluting stents in the calcified lesions of hemodialysis patients. J Cardiol. 2010;55:232–7.

    Article  PubMed  Google Scholar 

  27. Tamekiyo H, Hayashi Y, Toyofuku M, Ueda H, Sakuma T, Okimoto T, et al. Clinical outcomes of sirolimus-eluting stenting after rotational atherectomy. Circ J. 2009;73:2042–9.

    Article  PubMed  Google Scholar 

  28. Higashitani M, Mori F, Yamada N, Arashi H, Kojika A, Hoshi H, et al. Efficacy of paclitaxel-eluting stent implantation in hemodialysis patients. Heart Vessels. 2011;26:582–9.

    Article  PubMed  Google Scholar 

  29. Milavetz JJ, Miller JD, Hodge DO, Holmes DR, Gibbons RJ. Accuracy of single-photon emission computed tomography myocardial perfusion imaging in patients with stents in native coronary arteries. Am J Cardiol. 1998;82:857–61.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan

    Hiroaki Tsujita, Yuji Hamazaki, Tenjin Nishikura, Hiroyuki Yokota, Seita Kondo, Satoshi Hosokawa, Shigeto Tsukamoto, Mitsunori Mutou, Masayuki Sakurai, Hideki Nishimura & Youichi Kobayashi

Authors
  1. Hiroaki Tsujita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuji Hamazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tenjin Nishikura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroyuki Yokota
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Seita Kondo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Satoshi Hosokawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shigeto Tsukamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mitsunori Mutou
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Masayuki Sakurai
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Hideki Nishimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Youichi Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroaki Tsujita.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsujita, H., Hamazaki, Y., Nishikura, T. et al. Sirolimus-eluting stents versus paclitaxel-eluting stents for coronary intervention in patients with renal failure on hemodialysis. Cardiovasc Interv and Ther 28, 9–15 (2013). https://doi.org/10.1007/s12928-012-0103-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12928-012-0103-6

Keywords

Search

Navigation